Back to results
US 11,298,361 B2Granted
Fused benzazepines for treatment of Tourette's Syndrome
AssigneeEmalex Biosciences, Inc.
InventorsRichard E. Chipkin, Rudolf Kwan
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeEmalex Biosciences, Inc.
InventorsRichard E. Chipkin, Rudolf Kwan
Estimating the term…
The present invention encompasses methods of treating a subject who has been diagnosed as having a tic disorder or a movement disorder. The tic disorder can be Tourette's Syndrome, and the methods can include the steps of: (a) identifying a subject in need of treatment; and (b) administering to the subject a therapeutically effective amount of a composition comprising a D1/D5 receptor antagonist, a D1/D5 receptor partial agonist, or a mixture thereof. For example, the D1/D5 receptor antagonist can be ecopipam or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, structural analog, metabolite, or polymorph thereof.
A method of treating Tourette's disorder in a human patient in need thereof, the method comprising:
A method of treating Tourette's Disorder in a human patient in need thereof, the method comprising
A method of treating Tourette's Disorder in a human patient in need thereof and not older than 18 years, comprising administering to the patient once daily oral dosages of ecopipam or a pharmaceutically acceptable salt thereof in a unit dosage form comprising 10 mg to 200 mg ecopipam or a pharmaceutically acceptable salt thereof.
A method of treating Tourette's Disorder in a human patient in need thereof and not older than 18 years, comprising administering to the patient once daily oral dosages of ecopipam or a pharmaceutically acceptable salt thereof at a daily dose in a range of about 0.1 mg/kg to about 5 mg/kg.
Dependencies are inferred from the claim text.